drugset / Trial / NCT02955368

Clinical Trial to Evaluate the Efficacy and Safety of DP-R212

NCT02955368

Phase 3 Withdrawn Alvogen Korea
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine superiority of DP-R212 comparing to each monotherapy in patient with hypertension and primary hypercholesterolemia.

Timeline

Start
2017-02
Primary completion
2017-07
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator C1-R212 Unknown
Comparator C2-R212 Unknown
Subject DP-R212 Unknown